Sector: Medical Device

Subsector: Detal

Geography: Israel

Regulatory status: Class 3 clinical trials


CoreBone has developed a strong, bioactive coral bone graft for dental and orthopedic indications. The biomimetic bone graft offers a set of bonelike qualities, such as strength, porosity, resorption, and bioactivity, without being derived from human or animal bone.

The company’s bone graft is made from coral that is cultured in a closely monitored system, providing better control in enriching the graft with silicium and strontium for bioactivity and increased strength.

CoreBone has been awarded CE approval, and FDA 510K submission is planned for mid-2017. CoreBone products are CE and ISO 13485 certified.